NCT04626258

Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis

A Randomized Controlled Trial to Compare the Efficacy of a Medical Grade Honey Formulation (L-Mesitran®) and Fluconazol (Diflucan®) for the Treatment of Recurrent Vulvovaginal Candidiasis

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 252 (estimated)
• Sponsor: Maastricht University Medical Center · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the efficacy of Flucanzol versus L-mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. The investigator will look at vaginal swabs after 1, 6 and 12 months. The investigator included 252 patients.

Conditions

• Candidiasis, Vulvovaginal
• Recurrent Candidiasis of Vagina

Interventions

Type	Name	Description
DRUG	Fluconazole	Fluconazol once a month 150 mg capsule
OTHER	L-Mesitran	The first month apply every day one sachet, the next five months apply every week one sachet.

Timeline

• Start date: 2021-03-01
• Primary completion: 2024-03-01
• Completion: 2025-03-01
• First posted: 2020-11-12
• Last updated: 2020-11-12